Mesoblast Limited logo

Mesoblast Limited

MESO | NASDAQ
Chart Builder DCF Calculator
$15.82
+$0.34 (+2.20%)
Sep 22, 2026, 1:28 PM ET · Market open
Fiscal Year
Period Ending
FY 2026
Jun 29, 2026
FY 2025
Jun 29, 2025
FY 2024
Jun 29, 2024
FY 2023
Jun 29, 2023
FY 2022
Jun 29, 2022
FY 2021
Jun 29, 2021
Cash & Equivalents
47.39M 161.16M 62.56M 70.92M 60.03M 136.88M
Short-Term Investments
n/a n/a n/a n/a n/a n/a
Long-Term Investments
n/a 1.39M 1.01M 1.76M 1.76M 2.08M
Other Long-Term Assets
1.2M 1.3M 2.1M 481K 1.68M 1.72M
Receivables
57.66M 14.87M 20.95M 7M 4.4M 4.59M
Inventory
28.11M 22.25M n/a n/a n/a -252K
Other Current Assets
55.52M 393K 397K 398K 413K 451K
Total Current Assets
197.49M 204.35M 86.46M 81.66M 69.84M 148.23M
Property-Plant & Equipment
8.01M 5.82M 3.84M 6.49M 9.97M 12.14M
Goodwill & Intangibles
566.37M 571.83M 575.74M 577.18M 578.65M 580.55M
Total Long-Term Assets
575.59M 580.33M 582.69M 587.76M 592.31M 596.49M
Total Assets
773.08M 784.68M 669.15M 669.42M 662.14M 744.72M
Account Payables
34.51M 19.08M 7.07M 20.15M 23.08M 19.6M
Deferred Revenue
n/a n/a n/a 6.4M 17.91M -55.97M
Short-Term Debt
10.6M 54.16M 13.86M 5.95M 5.02M 53.2M
Other Current Liabilities
20.68M 26.71M 49.69M 5.43M 2.19M 18.71M
Total Current Liabilities
81.11M 102.63M 73.24M 41.98M 51.37M 94.27M
Long-Term Debt
108.64M 67.74M 100.48M 102.81M 91.62M 41.05M
Other Long-Term Liabilities
9.86M 13.29M 13.12M 19.11M 15.02M 19.52M
Total Long-Term Liabilities
123.56M 84.62M 115.56M 125.6M 113.73M 69.05M
Total Liabilities
204.67M 187.24M 188.8M 167.58M 165.1M 163.32M
Total Debt
127.33M 128.16M 118.92M 116.5M 106.91M 105.5M
Book Value
568.41M 597.44M 480.36M 501.84M 497.04M 581.4M
Book Value Per Share
4.39 4.95 4.87 5.98 7.28 9.61
Common Stock
1.53B 1.51B 1.31B 1.25B 1.17B 1.16B
Retained Earnings
-1.07B -1.01B -908.76M -820.81M -738.92M -647.57M
Comprehensive Income
106.03M 99.5M 78.3M 73.52M 70.65M 65.81M
Shareholders Equity
568.41M 597.44M 480.36M 501.84M 497.04M 581.4M
Total Investments
n/a 1.39M 1.01M 1.76M 1.76M 2.08M

© 2026 bestshares.com. All rights reserved.